A global review from the University of Toulouse found cannabis users face double the risk of cardiovascular-related death and a 20% increased stroke risk. Analysis of 24 studies (2016–2023) suggests inhaled cannabis—though consumption types vary—may elevate acute coronary syndrome risk by 29%. Researchers suggest public health policies should address these cardiovascular hazards with proper education, labeling, and marketing restrictions similar to tobacco. Ongoing research will clarify if risks differ with edibles or synthetic cannabinoids.

Source: The Guardian theguardian.com